Post-publication critique at top-ranked journals across scientific disciplines: A cross-sectional assessment of policies and practice — Tom E Hardwicke (2022) | RDL Network
Post-publication critique at top-ranked journals across scientific disciplines: A cross-sectional assessment of policies and practice
Preprint 2022 en
Authors
TH
Tom E Hardwicke
RT
Robert T. Thibault
JK
Jessica Elizabeth Kosie
Abstract
1 min read
Journals exert considerable control over letters, commentaries, and online comments that criticize prior research (post-publication critique). We assessed policies (Study One) and practice (Study Two) related to post-publication critique at 15 top-ranked journals in each of 22 scientific disciplines (N=330 journals). 207 (63%) journals accepted post-publication critique and often imposed limits on length (median 1000, interquartile range [IQR] 500-1200 words) and time-to-submit (median 12, IQR 4-26 weeks). The most restrictive limits were 175 words and 2 weeks; some policies imposed no limits. Of 2066 randomly sampled research articles published in 2018 by journals accepting post-publication critique, 39 (1.9%, 95% confidence interval [1.4, 2.6]) were linked to at least one post-publication critique (there were 58 post-publication critiques in total). Of the 58 post-publication critiques, 44 received an author reply, of which 41 asserted that original conclusions were unchanged. Clinical Medicine had the most active culture of post-publication critique: all journals accepted post-publication critique and published the most post-publication critique overall, but also imposed the strictest limits on length (median 400, IQR 400-550 words) and time-to-submit (median 4, IQR 4-6 weeks). Our findings suggest that top-ranked academic journals often pose serious barriers to the cultivation, documentation, and dissemination of post-publication critique.
Tom E Hardwicke, Robert T. Thibault, Jessica Elizabeth Kosie, Loukia Tzavella, Theiss Bendixen, Sarah A. Handcock, Vivian E. Köneke, John P A Ioannidis
Discussion(0)
No comments yet. Be the first to comment.